Literature DB >> 15558501

Radiation esophagitis: Predictive factors and preventive strategies.

Jeffrey Bradley1, Benjamin Movsas.   

Abstract

Radiation esophagitis remains the primary dose-limiting acute toxicity in the radiotherapeutic management of thoracic neoplasms. Improved understanding of this toxicity will facilitate dose escalation and enhancement of the therapeutic ratio. This article reviews the predictive factors and preventive strategies for radiation esophagitis. In particular, clinical and dosimetric studies predicting the risk of radiation esophagitis are analyzed. The critical impact of chemotherapy on radiation esophagitis is characterized. Preventive strategies to minimize this toxicity also are explored. Overall, this article reviews the current understanding of radiation toxicity for the esophagus.

Entities:  

Mesh:

Year:  2004        PMID: 15558501     DOI: 10.1016/j.semradonc.2004.06.003

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  14 in total

1.  Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.

Authors:  J M Bowen; I White; L Smith; A Tsykin; K Kristaly; S K Thompson; C S Karapetis; H Tan; P A Game; T Irvine; D J Hussey; D I Watson; D M K Keefe
Journal:  Support Care Cancer       Date:  2015-03-27       Impact factor: 3.603

2.  Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients.

Authors:  Ellen X Huang; Jeffrey D Bradley; Issam El Naqa; Andrew J Hope; Patricia E Lindsay; Walter R Bosch; John W Matthews; William T Sause; Mary V Graham; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-14       Impact factor: 7.038

Review 3.  Gastrointestinal toxicity associated to radiation therapy.

Authors:  Mario López Rodríguez; Margarita Martín Martín; Laura Cerezo Padellano; Alicia Marín Palomo; Yamile Ibáñez Puebla
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

4.  Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

Authors:  Karl Wurstbauer; Florian Merz; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

5.  (18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.

Authors:  Joshua S Niedzielski; Jinzhong Yang; Zhongxing Liao; Daniel R Gomez; Francesco Stingo; Radhe Mohan; Mary K Martel; Tina M Briere; Laurence E Court
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-07-21       Impact factor: 7.038

6.  Therapeutic effect of compound of White Peony Root Oral Liquids on radiation-induced esophageal toxicity via the expression of EGF and TGF-β1.

Authors:  Li Shen; Xing Li; Baoen Shan; Li Zhang; Yanjun Gong; Zhiming Dong; Zhiyu Wang
Journal:  Biomed Rep       Date:  2012-12-21

7.  Independent test of a model to predict severe acute esophagitis.

Authors:  Ellen X Huang; Clifford G Robinson; Alerson Molotievschi; Jeffrey D Bradley; Joseph O Deasy; Jung Hun Oh
Journal:  Adv Radiat Oncol       Date:  2016-11-16

Review 8.  Radiation-induced esophagitis in lung cancer.

Authors:  Sarah Baker; Alysa Fairchild
Journal:  Lung Cancer (Auckl)       Date:  2016-10-13

9.  Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.

Authors:  Hideomi Yamashita; Ryousuke Takenaka; Mami Omori; Toshikazu Imae; Kae Okuma; Kuni Ohtomo; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2015-08-14       Impact factor: 3.481

10.  Radiation-Induced Esophagitis is Mitigated by Soy Isoflavones.

Authors:  Matthew D Fountain; Lisa M Abernathy; Fulvio Lonardo; Shoshana E Rothstein; Michael M Dominello; Christopher K Yunker; Wei Chen; Shirish Gadgeel; Michael C Joiner; Gilda G Hillman
Journal:  Front Oncol       Date:  2015-10-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.